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A B S T R A C T
Purpose: It is estimated that approximately 20–30% of patients diagnosed with epilepsy have been
misdiagnosed, and neurocardiogenic syncope (NCS) might frequently be the real cause of transient loss
of consciousness (TLOC) episodes.
We assessed the role of the head-up tilt test (HUTT) in patients previously diagnosed with refractory
epilepsy to evaluate the ability of this test to correctly diagnose patients with NCS.
Method: We retrospectively analysed the clinical records of 107 consecutive patients with a previous
diagnosis of refractory epilepsy that were taking antiepileptic drugs and who were referred for HUTT
between January 2000 and December 2010. During the subsequent follow-up, we recorded the
treatments performed and the recurrence of symptoms.
Results: Complete follow-up data were available for 94 (88%) patients, and the mean follow-up period
was 80  36 months. The HUTT was positive in 54% of patients. Thirty-one (33%) patients were misdiagnosed
with epilepsy, and 20 (21%) patients had a dual diagnosis of NCS and epilepsy. The recurrence of TLOC was
reported in 55% of the patients, but it was signiﬁcantly lower in the misdiagnosed group (42% versus 64%;
P = 0.039).
Conclusion: NCS is an important cause of epilepsy misdiagnosis. The HUTT is often critical for making an
accurate diagnosis and subsequently selecting the appropriate treatment for patients presenting with
TLOC. The diagnostic overlap between epilepsy and NCS is not uncommon, suggesting that
electroencephalographic monitoring during a HUTT may play an important role in diagnosing patients
with recurrent, undiagnosed TLOC episodes.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy and syncope, two prevalent clinical conditions, are
frequently initially diagnosed incorrectly.1,2 Transient loss of
consciousness (TLOC) associated with involuntary motor activity is
sometimes mistaken for epilepsy and, consequently, antiepileptic
drugs (AEDs) are often prescribed in these circumstances.3,4 It is
estimated that 20–30% of patients diagnosed with epilepsy have
been misdiagnosed, and neurocardiogenic syncope (NCS) might be
the most frequent cause of this mistake.4,5 An incorrect diagnosis* Corresponding author at: Alameda Prof. Hernaˆni Monteiro, 4200-319 Porto,
Portugal. Tel.: +351 966462512.
E-mail address: inesrang@gmail.com (I. Rangel).
http://dx.doi.org/10.1016/j.seizure.2014.02.004
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prognostic deductions, which can subsequently cause refractory
therapy, adverse secondary effects of the AED, symptom recur-
rence, and a delayed identiﬁcation of the real TLOC cause.
When differentiating between syncope and epilepsy, it is
extremely helpful to carefully and methodically analyse the
patient’s history.6 However, a complete and accurate history
may not be sufﬁcient to differentiate between the two clinical
entities, and the head-up tilt test (HUTT) has already proven to be a
valuable diagnostic tool when investigating unexplained TLOC.7
Nonetheless, it is not well established how prevalent a dual
diagnosis of NCS and epilepsy is or how a systematic performance
of the HUTT and an electroencephalogram (EEG) test in patients
with TLOC might help to achieve a more accurate diagnosis. In
patients with refractory TLOC, we aimed to assess the role of theserved.
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NCS and epilepsy, and the frequency of symptom recurrence in a
long-term follow-up for each group.
2. Methods
In this study, we retrospectively analysed the clinical records of
107 patients with a prior diagnosis of refractory epilepsy that were
taking AEDs and who were consecutively referred to an Autonomic
Clinic for HUTT between January 2000 and December 2010.
Exclusion criteria included patients without an available EEG.
Refractory epilepsy was deﬁned as a failure to achieve a
sustained absence of seizures following two trials of tolerated and
appropriately chosen AED regimens of either mono- or combina-
tion therapy.8 The diagnosis of refractory epilepsy was established
by the patient’s neurologist and was based on symptom
recurrence, which was occasionally associated with dubious
clinical manifestations. The epileptiform activity on EEGs was
deﬁned as characteristic waves or wave complexes, distinct from
the background activity, and resembling those recorded in a group
of human subjects suffering from epileptic disorders.9
When the patients underwent the HUTT, they completed a
questionnaire to obtain clinical details including pre- and post-
TLOC symptoms. The HUTT was performed according to the
guidelines of the European Society of Cardiology, which involves a
708 upright head-up tilt in an electric tilt table with footplate
support and body straps for up to 40 min. Blood pressure was
monitored using digital photoplethysmography (Finapres1), and
an electrocardiogram was continuously recorded throughout the
study. When no syncopal event was observed during the tilting
phase (baseline), sublingual nitrates were administered. Patients
over 40 years of age were also examined with bilateral carotid
massage, which was performed in the supine position and after a
prolonged orthostasis whenever there was no contraindication. A
positive HUTT required the presence of syncope or pre-syncope,
associated with the reproduction of usual clinical symptoms, and a
signiﬁcant sudden drop in blood pressure and/or heart rate.Table 1
Clinical characteristics according to ﬁnal clinical diagnosis.
Variables Total (N = 94; 100%) Epilepsy (N =
Age (years), mean (SD) 39 (17) 40 (15) 
Female, N (%) 67 (71) 27 (69) 
Episode frequency
Weekly 3 (3) 2 (5) 
Monthly 28 (30) 14 (36) 
Bi-annually 31 (33) 9 (23) 
Annually 32 (34) 14 (36) 
Prodromal/associated signs and symptoms
Visual symptoms 50 (53) 21 (54) 
Dizziness and light-headedness 62 (66) 26 (67) 
Diaphoresis 34 (36) 13 (33) 
Palpitations 33 (35) 17 (44) 
Nausea/vomiting 17 (18) 8 (21) 
Pallor 33 (35) 13 (33) 
Asthenia 49 (52) 22 (56) 
Myoclonic movements 71 (76) 34 (87) 
Sphincter incontinence 18 (19) 12 (31) 
History of trauma 32 (34) 19 (49) 
Precipitated by standing position 59 (63) 20 (52) 
Comorbidities
Hypertension 10 (11) 3 (8) 
Diabetes mellitus 4 (4) 1 (3) 
Cardiac disease 2 (2) 2 (5) 
Psychiatric disease 4 (4) 2 (5) 
* Statistical signiﬁcance for p value < 0.05.A ﬁnal clinical diagnosis was supported by a consensus between
a neurologist and a cardiologist and was based on the patient’s
clinical features and the results of the HUTT and the EEG (Table 1):
 Epilepsy alone: negative HUTT and symptoms and EEG consis-
tent with epilepsy.
 NCS alone: typical clinical reproduction of symptoms during the
HUTT and symptoms and EEG not consistent with epilepsy.
 Dual diagnosis of epilepsy and NCS: typical clinical reproduction
during the HUTT of some of the patients’ symptoms, but
coexistence of other episodes, symptoms and EEG consistent
with epilepsy.
 TLOC of unknown cause: unspeciﬁc symptoms, negative HUTT
and EEG not consistent with epilepsy.
The patients’ subsequent follow-up was performed via a
telephone interview to evaluate their clinical evolution, including
treatments performed and symptom recurrence. Clinical records
for each patient were carefully reviewed to complete the
information regarding symptom recurrence as well as type and
date of clinical outcomes. We considered clinical outcome a
recurrence of sudden spontaneous TLOC, which presented with the
same characteristics of the previous episodes.
2.1. Statistical analysis
We calculated the mean of continuous variables and the
frequency of categorical variables. Comparisons were made using
ANOVA (Scheffe’s F test) for continuous variables, and the chi-
square test was used for categorical variables. The cumulative
proportion of TLOC recurrence was estimated via the Kaplan–
Meier method by plotting proportion recurrences as a function of
time. The survival curves according to the ﬁnal diagnosis (NCS
versus epilepsy/dual diagnosis) were compared using the log-rank
test. Two-tailed P-values < 0.05 were considered statistically
signiﬁcant. Statistical analysis was performed using SPSS Statistics
version 19.0 (SPSS Inc., Chicago, IL). 39; 41%) NCS (N = 31; 29%) Dual (N = 20; 21%) P value
33 (16) 41 (18) 0.160
22 (71) 15 (75) 0.898
1 (3) 0 (0) 0.457
7 (23) 5 (25)
14 (45) 7 (35)
9 (29) 8 (40)
18 (58) 9 (45) 0.657
21 (68) 12 (60) 0.835
13 (42) 8 (40) 0.742
7 (23) 7 (35) 0.185
7 (23) 2 (10) 0.198
11 (35) 7 (35) 0.981
17 (55) 9 (45) 0.693
22 (71) 15 (75) 0.098
3 (10) 3 (15) 0.074
7 (23) 6 (30) 0.064
23 (74) 14 (70) 0.111
4 (13) 2 (10) 0.253
0 (0) 2 (10) 0.142
0 (0) 0 (0) 0.516
0 (0) 0 (0) 0.920
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Of the nearly 3800 patients that had a HUTT performed
between 2000 and 2010, 174 patients (4.6%) were diagnosed with
‘‘refractory epilepsy’’ and were taking AEDs. Of these, 107 patients
with at least one EEG available were included in the study
population. The study population consisted of 68% females and an
overall mean age of 38  17 years. Only 3% of the patients reported
frequent (weekly) episodes of TLOC. Regarding prodromal or
associated features, 86% of the patients reported limb movements,
19% reported sphincter incontinence and 63% mentioned episode
occurrence in the standing position. Trauma was also relatively
frequent (34%) in this patient population.
An inadequate or missing history (no witness and/or poor
description regarding associated symptoms) was present in 23% of
the study population. Doubts regarding the accuracy of the
previously established diagnosis (epilepsy) were the most
common reason (91%) of referral for HUTT. Some patients (9%)
were also referred for HUTT due to the clinician’s suspicion of a
dual diagnosis of epilepsy and NCS.
Follow-up data were available for 94 (88%) patients, with a
mean follow-up period of 80  36 months. These patients presented
a mean age of 39  17 years, and 67 (71%) patients were women.
Fifty-one patients (54%) experienced their usual symptoms during
the HUTT, which were associated with profound hypotension and/or
bradycardia that is consistent with a clinical diagnosis of NCS
(vasodepressor response in 57%, cardioinhibitory in 6%, and mixed in
37%).
The ﬁnal clinical diagnostic groups and patients’ main clinical
characteristics are presented in Table 1. Forty-one percent of
patients were classiﬁed as having only epilepsy, 33% were
classiﬁed as having only NCS, 21% were classiﬁed as having a
dual diagnosis of epilepsy and NCS, and 4% of the patients were
unable to be classiﬁed as having epilepsy or NCS.
No signiﬁcant differences were found between the ﬁnal
diagnostic groups regarding anthropometric features, symptom
characteristics and comorbidities. There were no signiﬁcant
differences in the type of HUTT response between the misdiag-
nosed group and the dual diagnosis group (P > 0.05).
Carotid sinus syndrome was not present in this study
population.
All misdiagnosed patients stopped taking AEDs. Most of the
misdiagnosed patients were advised to increase salt and water
intake and perform physical counter pressure manoeuvres, while
some patients (15%) received new pharmacological treatments
(Midodrine and/or a beta-blocker).
3.1. TLOC recurrence
TLOC recurrence was reported in 55% of the patients (Table 2)
and recurrence was signiﬁcantly lower in the misdiagnosed group
of patients compared with the rest of the patient population (42%
versus 64%; P = 0.039). A tendency towards a lower rate of
symptom recurrence was observed in positive versus negative
HUTT groups (49% versus 69%, respectively; P = 0.066).Table 2
Syncope recurrence during the follow-up according to ﬁnal clinical diagnosis.
Diagnosis Patients, N (%) Symptom recurrence, N (%)
NCS 31 (33) 13 (42)
NCS + epilepsy 20 (21) 12 (60)
Epilepsy 39 (41) 24 (62)
Unknown cause 4 (4) 3 (75)
Total 94 (100) 52 (55)
NCS, neurocardiogenic syncope.The survival curves obtained for the groups based on ﬁnal
diagnosis (NCS alone versus dual diagnosis) are shown in Fig. 1. A
signiﬁcant difference regarding TLOC recurrence was observed in
patients with misdiagnosed epilepsy compared with the rest of the
patient population (log-rank test: P = 0.009). The mean time for
diagnosing TLOC recurrence in the misdiagnosed branch (NCS
alone) was 19  11 months compared to 10  7 months in the
epilepsy/dual diagnosis branch.
In the follow-up evaluation, none of the NCS patients had their
diagnosis changed to epilepsy.
4. Discussion
In this study, we addressed the usefulness of HUTT in patients
diagnosed with epilepsy. Here, we reported a signiﬁcant percent-
age (33%) of patients who were misdiagnosed and had a ﬁnal
diagnosis of NCS. Additionally, a dual diagnosis of NCS and epilepsy
was also frequently observed (21%). Interestingly, upon follow-up,
we found high rates of TLOC recurrence, in both patients with a
ﬁnal diagnosis of NCS and epilepsy, although the recurrence was
higher in the epilepsy group.
The difﬁculty in distinguishing epilepsy from NCS has long been
recognised.3 Although a detailed history and witness account are
essential for an accurate diagnosis, this may not be enough to
differentiate between the two clinical entities. Contributing factors
for misdiagnosing epilepsy are brief jerking or urinary inconti-
nence associated with TLOC, a family history of epilepsy, and
overvalorisation of minor abnormalities or normal-age speciﬁc
variants on EEGs.
The HUTT is an important tool for detecting NCS in patients
with TLOC of unknown aetiology. The HUTT test is safe, well
tolerated, and presents adequate sensitivity, speciﬁcity and
reproducibility, especially when symptoms are reproduced during
the test.7,10 This study included patients who were referred for the
HUTT to reassess whether the TLOC episodes were related to a NCS
instead of epilepsy (for example, due to a poor response to AEDs orFig. 1. Kaplan–Meier survival curves for TLOC recurrence according to the ﬁnal
clinical diagnosis: NCS (dashed line) and epilepsy  NCS (continuous line). The x-axis
shows months to the diagnosis of TLOC recurrence; the y-axis shows the proportion of
subjects remaining TLOC-free. NCS, neurocardiogenic syncope.
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diagnosis). Our data showed that the HUTT is a simple, non-
invasive tool that has an important role in conﬁrming or refuting a
diagnosis of NCS in patients with misdiagnosed epilepsy.
Accordingly, this test led to a change in the diagnosis of
approximately one-third of our patients.
It is essential to distinguish NCS from epilepsy because of
differences in prognosis and treatment. Dealing with this type of
syncope involves reassuring and counselling the patients on
several aspects, such as avoiding precipitating factors and
performing postural and counter pressure manoeuvres that can
abort TLOC when patients feel pre-syncopal symptoms.
NCS is a common symptom in the general population and has a
high recurrence rate.11 Although there is little mortality associated
with NCS, recurrent events can severely disable and may
signiﬁcantly inﬂuence the patient’s overall quality of life.12 In
this study, more than 40% of patients with a ﬁnal diagnosis of NCS
continued to faint. Nevertheless, it must be emphasised that this
study focused on a highly symptomatic cohort because the patients
were selected based on recurrent events. Although some
pharmacologic and non-pharmacological therapies may be bene-
ﬁcial to NCS patients, these therapies may be insufﬁcient to
prevent all recurrent episodes during a long follow-up period.13 To
the best of our knowledge, this is the longest follow-up study to
evaluate the usefulness of HUTT in patients with suspected
refractory epilepsy. Interestingly, none of the patients initially
diagnosed with NCS had a diagnosis of epilepsy during the follow-
up period, supporting the importance of HUTT in the diagnosis and
differential diagnosis of NCS.
In cases involving a clinical suspicion of NCS, an EEG should not
be requested because it would most likely not show speciﬁc
epileptiform discharges. Instead, an EEG would show only normal
phenomena or minor non-speciﬁc abnormalities that might lead to
misleading reports and inappropriately prescribing AEDs.14
There was no cardiac (arrhythmic) syncope diagnosis because
patients who were suspected of having this diagnosis were ﬁrst
observed by a cardiologist and only referred for the HUTT when
that suspicion was refuted following a full evaluation.
An incorrect diagnosis of epilepsy can also arise from
psychogenic non-epileptic seizures (PNES), which may occur in
up to 12% of cases.1 We reported four patients that had both their
epilepsy and NCS diagnoses refuted and whose TLOC aetiology was
still under investigation. It is possible that the patients with TLOC
of unknown aetiology were suffering from PNES.
The misdiagnosis of epilepsy may bring signiﬁcant clinical,
psychosocial and socioeconomic problems to the patient. Patients
may present AED intolerance, dose-related neurotoxicity and acute
allergic reactions, among other signiﬁcant side effects. It is
important to emphasise that a misdiagnosis naturally delays the
diagnosis of the real cause of TLOC. Additionally, it should be
mentioned that it might be complicated to overcome the negative
social consequences of a misdiagnosis of epilepsy.14
Additionally, there are considerable costs associated with an
incorrect diagnosis of drug-resistant epilepsy.15
A dual diagnosis of NCS and epilepsy following a HUTT
evaluation has been previously reported in one-third of patients
having a ﬁnal diagnosis of epilepsy.16 In our study, roughly one-
ﬁfth of the total TLOC population was diagnosed with both NCS and
epilepsy.
The key element in NCS is transient global cerebral ischaemia
secondary to severe hypotension, bradycardia, or both. Studies
have shown that electroencephalographic characteristics related
to the NCS (due to the transient cerebral anoxia) are quite
distinctive from those associated with epilepsy. In patients with
reﬂex syncope, EEG monitoring during the HUTT could provide
valuable data to support the interpretation of seizure-likeepisodes. In patients who presented with myoclonic jerky move-
ments during a HUTT-induced syncope, EEG was useful for
demonstrating how the theta and delta waves slowed without a
spike or spike-wave activity.17 Therefore, we believe that
electroencephalographic monitoring during the HUTT could have
an important role in obtaining the most accurate diagnosis for
patients with recurrent non-diagnosed TLOC.
The retrospective and single centre, non-randomised nature of
this study may present limitations for our results. Only patients
referred for the HUTT were selected to participate in this study, and
we could not control the selection criteria for this referral.
Additionally, we did not perform an EEG during the HUTT.
5. Conclusion
The NCS is an important frequent cause of misdiagnosed
epilepsy. The HUTT is crucial for obtaining an accurate diagnosis
and to select the appropriate treatment for patients with TLOC to
reduce its recurrence. A diagnostic overlap of epilepsy and NCS is
not uncommon, suggesting that electroencephalographic moni-
toring during the HUTT may play an important role in patients
manifesting with recurrent undiagnosed blackouts.
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